Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
Fuji
Daiichi Sankyo
UBS
Federal Trade Commission
Cantor Fitzgerald
AstraZeneca
Queensland Health

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021260

« Back to Dashboard

NDA 021260 describes AVINZA, which is a drug marketed by King Pharms Llc and is included in one NDA. It is available from one supplier. Additional details are available on the AVINZA profile page.

The generic ingredient in AVINZA is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
Summary for 021260
Tradename:AVINZA
Applicant:King Pharms Llc
Ingredient:morphine sulfate
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 021260
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 021260
Suppliers and Packaging for NDA: 021260
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260 NDA Bryant Ranch Prepack 63629-3765 E 63629-3765-1
AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260 NDA Bryant Ranch Prepack 63629-3766 E 63629-3766-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength30MG
Approval Date:Mar 20, 2002TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength60MG
Approval Date:Mar 20, 2002TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE, EXTENDED RELEASE;ORALStrength90MG
Approval Date:Mar 20, 2002TE:RLD:No

Expired US Patents for NDA 021260

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-004 Mar 20, 2002 ➤ Sign Up ➤ Sign Up
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-006 Dec 18, 2008 ➤ Sign Up ➤ Sign Up
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-001 Mar 20, 2002 ➤ Sign Up ➤ Sign Up
King Pharms Llc AVINZA morphine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021260-003 Mar 20, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Dow
Johnson and Johnson
Fish and Richardson
Cerilliant
US Army
Farmers Insurance
QuintilesIMS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.